| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A perspective on the regulation of the evaluation of new antithrombotic drugs
|
Califf, Robert M
|
|
1998
|
82 |
8S1 |
p. 25P-35P
nvt p.
|
artikel
|
| 2 |
A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina
|
Bittl, John A.
|
|
1998
|
82 |
8S1 |
p. 43P-49P
nvt p.
|
artikel
|
| 3 |
Current issues in reperfusion therapy
|
Gersh, Bernard J.
|
|
1998
|
82 |
8S1 |
p. 3P-11P
nvt p.
|
artikel
|
| 4 |
Direct thrombin inhibition and thrombolytic therapy: rationale for the hirulog and early reperfusion/occlusion (HERO-2) trial
|
White, Harvey D
|
|
1998
|
82 |
8S1 |
p. 57P-62P
nvt p.
|
artikel
|
| 5 |
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin
|
Bates, Shannon M
|
|
1998
|
82 |
8S1 |
p. 12P-18P
nvt p.
|
artikel
|
| 6 |
Evolution of improved antithrombotic and antiplatelet agents: genesis of the comparison of abciximab complications with hirulog [and back-up abciximab] events trial (CACHET)
|
Topol, Eric J.
|
|
1998
|
82 |
8S1 |
p. 63P-68P
nvt p.
|
artikel
|
| 7 |
Heparin dosing in patients undergoing coronary intervention
|
Popma, Jeffrey J
|
|
1998
|
82 |
8S1 |
p. 19P-24P
nvt p.
|
artikel
|
| 8 |
Introduction
|
Topol, Eric J.
|
|
1998
|
82 |
8S1 |
p. 1P-2P
nvt p.
|
artikel
|
| 9 |
Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty
|
Bittl, John A
|
|
1998
|
82 |
8S1 |
p. 50P-56P
nvt p.
|
artikel
|
| 10 |
Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
|
Lincoff, A.Michael
|
|
1998
|
82 |
8S1 |
p. 36P-42P
nvt p.
|
artikel
|
Tijdschrift beschrijving